Abstract
Basic fibroblast growth factor (bFGF) belongs to the family of the heparin-binding growth factors which includes also acidic FGF and five other gene products (Basilico and Moscatelli, 1992). bFGF exerts various biological activities in vitro and in vivo on different cell types. In particular, bFGF is an angiogenic molecule that induces a set of complex, coordinated responses in cultured endothelial cells, including cell proliferation, chemotaxis, and protease production (Presta et al., 1986). The identification of the functional domains of bFGF appears to be of pivotal importance for the development of drugs aimed to stimulate or to inhibit angiogenesis in various pathological conditions. In the present paper we will summarize findings from different laboratories on the structure-function relationship of this angiogenic growth factor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akiyama, S.K., and Yamada, K.M., 1985, Synthetic peptides competitively inhibit both direct binding to fibroblasts and functional biological assays for the purified cell-binding domain of fibronectin, J. Biol. Chem., 260: 10402.
Baird, A., Schubert, D., Ling, N., and Guillemin, R, 1988, Receptor-and heparin-binding domains of basic fibroblast growth factor, Proc. Natl. Acad. Sci. U.S.A. 85: 23–24.
Baldin, V., Roman, A.M., Bosc-Bieme, I., Amalric, F., and Bouche, G., 1990, Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells, EMBO J. 9: 1511.
Basilico, C., and Moscatelli, D., 1992, The FGF family of growth factors and oncogenes, Adv. Cancer Res. 59: 115.
Baskin, P., Doctrow, S., Klagsbrun, M., Svahn, C.M., Folkman, J. and Vlodaysky, I., 1989, Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules, Biochemistry 28: 1737.
Bouche, G., Gas, N., Prats, H., Baldin, V., Tauber, J.P., Teissié, J., and Amalric, F., 1987, Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing Go-G1 transition, Proc. Natl. Acad. Sci. U.S.A. 84: 67–70.
Breeuwer, M., and Goldfarb, D.S., 1990, Facilitated nuclear transport of histone Hl and other small nucleophilic proteins, Cell 60: 999.
Bugler,B., Amalric, F., and Prats, H., 1991, Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor, Mol. Cell. Biol. 11: 573.
Burgess, W.H., Bizik, J., Mehlman, T., Quarto, N., and Rifkin, D.B., 1991, Direct evidence for methylation of arginine residues in high molecular weight forms of basic fibroblast growth factor, Cell Regul. 2: 87.
Chelsky, D., Ralph, R, and Jonak, G., 1989, Sequence requirements for synthetic peptide-mediated translocation to the nucleus, Mol. Cell. Biol. 9: 24–87.
Coltrini, D., Rusnati, M., Zoppetti, G., Oreste, P., Iascchi, A., Caccia, P., Bergonzoni, L., and Presta, M., 1993, Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans: new insights from trypsin digestion studies, Eur. J. Biochem. in press.
Couderc, B., Prats, H., Bayard, F., and Amalric, F., 1991, Potential oncogenic effects of basic fibroblast growth factor requires cooperation between CUG and AUG-initiated forms, Cell Regul. 2: 709.
Dell’Era, P., Presta, M., and Ragnotti, G., 1991, Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells, Exp. Cell Res. 192: 505.
Eppstein, D.A., Marsh, Y.V., Schryver, B.B., and Bertics, P.J., 1989, Inhibition of epidermal growth factor/trasforming growth factor-a stimulated cell growth by a synthetic peptide, J. Cell. Physiol. 141: 420.
Eriksson, A.E., Cousens, L.S., Weaver, L.H., Matthews, B.W., 1991, Three-dimensional structure of human basic fibroblast growth factor, Proc. Natl. Acad. Sci. U.S.A. 88: 34–41.
Feige, J.J., Bradley, J.D., Fryburg, K., Farris, J., Cousens, L.C., Barr, P.J., and Baird, A., 1989, Differential effects of heparin, fibronectin, and laminin on the phosphorylation of basic fibroblast growth factor by protein kinase C and the catalytic subunit of protein kinase A, J. Cell Biol. 109: 3105.
Flaumenhaft, R, Moscatelli, D., Salcsela, O., and Rifkin, D.B., 1989, Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis, J. Cell. Physiol. 140: 75.
Flaumenhaft, R., Moscatelli, D., and Rifkin, D B, 1990, Heparin and heparan sulphate increase the radius of diffusion and action of basic fibroblast growth factor, J. Cell Biol. 111: 1651.
Florkiewicz, R.Z., and Sommer, A., 1989, Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc. Natl. Acad. Sci. U.S.A. 86: 39–78.
Florkiewicz, R.Z., Baird, A., and Gonzalez, A.M., 1991, Multiple forms of bFGF: differential nuclear and cell surface localization, Growth Factors 4: 265.
Gospodarowicz, D., Greenburg, G., and Birdwell, RC., 1978, Determination of cellular shape by the extracellular matrix and its correlation with the control of cellular growth, Cancer Res. 38: 41–55.
Gospodarowicz, D., and Cheng, J., 1986, Heparin protects basic and acidic FGF from inactivation, J. Cell. Physiol. 128: 475.
Gualandris, A., Coltrini, D., Bergonzoni, L., Isacchi, A., Tenca, S., Ginelli, B., and Presta, M., 1993, The N-terminal extension of high molecular weight forms of basic fibroblast growth factor (bFGF) is not essential for the binding of bFGF to nuclear chromatin in transfected NIH 3T3 cells, Growth Factors 8: 49.
Habazetti, J., Gondol, D., Wiltscheck, R., Otlewsky, J., Schleicher, M. and Holak, T.A., 1992, Structure of hisactophilin is similar to interleukin-1ß and fibroblast growth factor, Nature 359: 855.
Hageman, G.S., Kirchoff-Rempe, M.A., Lewis, G.P., Fisher, S.K., and Anderson, D.H., 1991, Sequestration of basic fibroblast growth factor in the primate retinal interphotoreceptor matrix, Proc. Natl. Acad. Sci. U.S.A. 88: 6706.
Hynes, RO., 1987, Integrins: a family of cell surface receptors, Cell 48: 549.
Imamura, T., Englera, K., Zhan, X., Tokita, Y., Forough, R, Roeder, D., Jackson, A., Maier, J.A.M., Hia, T., and Maciag, T., 1990, Science 249: 15–67.
Imamura, T., Tokita, Y., and Mitsui, Y.,Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence, 1992, Identification of a heparin-binding growth factor-1 nuclear translocation sequence by deletion mutation analysis, J. Biol. Chem. 267: 56–76.
Ingber, D.E., Madri, J.A., and Folkman, J., 1987, Endothelial growth factors and extracellular matrix regulate DNA synthesis through modulation of cell and nuclear expansion, In Vitro Cell. Dev. Biol. 23: 387.
Ingber, D.E., and Folkman, J., 1988, Inhibition of angiogenesis through modulation of collagen metabolism, Lab. Invest., 59: 41.
Ingber, D.E., and Folkman. J., 1989, Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix, J. Cell Biol. 109: 317.
Ingber, D.E., 1990, Fibronectin controls capillary endothelial cell growth by modulating cell shape, Proc. Natl. Acad. Sci. U.S.A. 87: 35–79.
Ingber, D.E., Prusty, D., Frangioni, J.V., Cragoe, E.J.Jr., Lechene, C., and Schwartz, M.A., 1990, Control of intracellular pH and growth by fibronectin in capillary endothelial cells, J. Cell Biol. 110: 1803.
Isacchi, A., Statuto, M., Chiesa, R, Bergonzoni, L., Rusnati, M., Sarmientos, P., Ragnotti, G., and Presta, M., 1991, A 6-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity, Proc. Natl. Acad. Sci. U.S.A. 88: 26–28.
Johnson, D.E., and Williams, L.T., 1993, Structural and functional diversity in the FGF receptor multigene family, Adv. Cancer Res. 60: 1.
Katsuura, M., and Tanaka, S., 1989, Topographic analysis of human epidermal growth factor by monospecific antibodies and synthetic peptides, J. Biochem. 106: 87.
Klagsbrun, M., and Baird, A., 1991, A dual receptor system is required for basic fibroblast growth factor activity, Cell 67: 229.
Krstenansky, J., Trivedi, D., and Hruby, V.J., 1986, Importance of the 10–13 region of glucagon for its receptor interactions and activation of adenylate cyclase, Biochemistry 25: 3833.
Kurokawa, M., Doctrow, S.R., and Klagsbrun, M., 1989, Neutralizing antibodies inhibit the binding of fibroblast growth factor to its receptor but not to heparin, J. Biol. Chem., 264: 76–86.
Moscatelli, D., Joseph-Silverstein, J., Presta. M., and Rifkin, D.B., 1988, Multiple forms of an angiogenesis factor: basic fibroblast growth factor, Biochimie 70: 83.
Nestor, J.J., Newman, S R, DeLustro, B., Todaro, G.J., and Schreiber, A.B., 1985, A synthetic fragment of rat transforming growth factor-cc with receptor binding and antigenic properties, Biochem. Biophys. Res. Commun. 129: 226
Ornitz, D.M., Yayon, A., Flanagan, J.G., Svahn, C.M., Levi, E., and Leder, P, 1992, Heparin is required for cell-free binding of fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells, Mol. Cell. Biol. 12: 240.
Presta, M., Moscatelli, D., Joseph-Silverstein, J., and Rifkin, D.B., 1986, Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration, Mol. Cell. Biol. 6: 40–60.
Presta, M., Maier, J.A.M., Rusnati, M., and Ragnotti, G., 1989, Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form, J. Cell. Physiol. 140: 68.
Presta, M., Rusnati, M., Urbinati, C., Sommer, A., and Ragnotti, G., 1991, Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two asp-gly-argcontaining domains involved in the mitogenic activity of bFGF in endothelial cells, J. Cell. Physiol. 149: 524.
Presta, M., Statuto, M., Isacchi, A., Caccia, P., Pozzi, A., Gualandris, A., Rusnati, M., Bergonzoni, L., and Sarmientos, P., 1992, Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region, Biochem. Biophys. Res. Commun. 185: 1098.
Quarto, N., Talarico, D., Florkiewicz, R, and Rifkin, D B, 1991a, Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells, Cell Regul. 2: 699.
Quarto, N., Finger, F.P., and Rifkin, D.B., 1991b, The NH2- terminal extension of high molecular weight bFGF is a nuclear targeting signal, J. Cell. Physiol. 147: 311.
Renko, M., Quarto, N., Morimoto, T., and Rifkin, D.B., 1990, Nuclear and cytoplasmic localization of different basic fibroblast growth factor species, J. Cell. Physiol. 144: 108.
Ruoslathi, E., and Piershbacher, M.D., 1986, Arg-Gly-Asp: a versatile cell recognition signal, Cell 44: 517.
Ruoslathi, E., and Piershbacher, M.D., 1987, New perspectives in cell adhesion: RGD and integrins, Science 238: 493.
Schubert, D., Ling, N., and Baird, A., 1987, Multiple influences of a heparin-binding growth factor on neuronal development, J. Cell Biol. 104: 635.
Seno, M., Saaada, R, Kurokawa, T., and Igarashi, K., 1990, Carboxyl-terminal structure of basic fibroblast growth factor significantly contributes to its affinity for heparin, Eur. J. Biochem. 188: 239.
Silver, P.A., 1991, How proteins enter the nucleus, Cell 64: 489.
Sommer, A., and Rifkin, D B, 1989, Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan, J. Cell. Physiol. 138: 215.
Tessler, S., and Neufeld, G., 1990, Basic fibroblast growth factor accumulates in the nuclei of various bFGF-producing cell types, J. Cell. Physiol. 145: 310.
Vlodaysky, J., Folkman J., Sullivan, R, Fridman, R, IshaiMichaeli, R, Sasse, J., and Klagsbrun, M., 1987, Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix, Proc. Acad Sci. U.S.A. 84: 22–92.
Vlodaysky, I., Bar-Shavit, R, Ishai-Michaeli, R, Bashkin, P., and Fuks, Z., 1991, Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem. Sci. 16: 268.
Walicke, P.A., Feige J. J., and Baird, A., 1989, Characterization of the neuronal receptor for basic fibroblast growth factor and comparison to receptors on mesenchymal cells, J. Biol. Chem. 264: 4120.
Walicke, P.A., and Baird, A., 1991, Internalization and processing of basic fibroblast growth factor by neurons and astrocytes, J. Neurosci. 11: 22–49.
Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P., and Ornitz, D.M., 1991, Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor, Cell 64: 841.
Zhang, J., Cousens, L.S., Barr, P.J., and Sprang, S.R, 1991, Three-dimensional structure of human basic fibroblast growth factor, a structural homolog to interleukin-113, Proc. Natl. Acad. Sci. U.S.A. 88: 34–46.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Presta, M. et al. (1994). Human Basic Fibroblast Growth Factor: Structure-Function Relationship of an Angiogenic Molecule. In: Maragoudakis, M.E., Gullino, P.M., Lelkes, P.I. (eds) Angiogenesis. NATO ASI Series, vol 263. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9188-4_5
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9188-4_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9190-7
Online ISBN: 978-1-4757-9188-4
eBook Packages: Springer Book Archive